CD274 and neoplasm: In this study, we uncovered two ESEs required for the inclusion of exon 3 and designed two antisense oligonucleotides (mt21 ASO-4 and mt29 ASO-4) that suppressed the surface PD-L1 expression of tumor cells by blocking these two ESEs and promoting PD-L1 exon 3 skipping.